The toxic, mutagenic, and carcinogenic effects of alkylating agents have been attributed to their ability to damage DNA. Reaction at the 06 position of guanine results in miscoding during DNA replication, has been shown to be mutagenic in both bacteriophage and bacteria, and may be responsible for malignant transformation. In common with many other prokaryotes and eukaryotes the Escherichia coli B
The mechanism by which alkylating agents exert their toxic, mutagenic, teratogenic, and carcinogenic effects in prokaryotes and various animal model systems are believed to be related to their interaction with DNA (1, 2) . The oxygen and some of the nitrogen atoms in DNA can be alkylated after exposure to such agents, and many organisms have evolved mechanisms whereby some ofthese products can be repaired (3) , resulting in a reduction in the genotoxic effects. Of the 12 reaction products in DNA (3), 06-alkylation of guanine has been the focus of Considerable attention since its ability to cause misincorporation of thymine during DNA replication (4) was demonstrated in in vitro polymerase assays (3, 5) . It has been shown in a variety of laboratory rodents that tumor induction by alkylating agents generally occurs in species whose tissues are less able to repair 06-alkylguanine (06-AG) in DNA (6) (7) (8) . The recent reports (9, 10) that N-methyl-Nnitrosourea (MNU)-induced mammary tumors in rats contain G-*A transition mutations at position 35 ofthe Ha-ras-1 gene may be an example of the involvement of 06-AG in carcinogenesis. Furthermore, cultured mammalian cells that are deficient in the ability to repair 06-AG are sometimes more susceptible to the toxic effects of alkylating agents than repair-proficient cells (11) (12) (13) , and the induction of mutations correlates with 06-alkylation (14-16) although other lesions may also be involved (3, 17) . Since alkylating agents react with many other cellular constituents, including RNA, protein, lipids, and low molecular weight compounds (8) , one method of investigating the precise role of 06-AG in DNA in the biological effects of alkylating agents would be to clone the gene coding for the repair protein and to express it in repair-deficient cells and eventually in whole animals.
Repair of 06-AG was first demonstrated in Escherichia coli (18) , and the mechanism in both prokaryotes and eukaryotes involves the transfer of the alkyl group to a cysteine residue within the protein itself, a process that is autoinactivating (19) . We (20) and others (21) (22) (23) (24) (25) have cloned the E. coli gene for 06-AG alkyltransferase (ATase), which is identical to the ada gene (21) , and we found it encodes a 37-kDa protein that displays activity on both 06-AG and alkylphosphotriesters (AP) in DNA (20, 22) . The protein can undergo hostdependent cleavage to active subfragments (20) . The ada gene had earlier been shown to regulate the "adaptive" response of E. coli during which exposure to low doses of N-methyl-N-nitro-N-nitrosoguanidine increases resistance to the toxic and mutagenic effects of challenging doses of the same agent (26, 27) .
Recently (28) , we obtained transient expression of the E. coli gene by insertion of the coding sequence into the vector pSV2 (29) and transfection into COS-7 monkey fibroblasts (30) . However, exploitation of this system was restricted by the presence of endogenous ATase activity and the requirement for simian virus 40 replication-permissive hosts. We now describe the construction of a retrovirus-based antibiotic-resistance selectable plasmid containing the E. coli 06-AG ATase gene and its permanent expression in Chinese hamster V79 cells that lack endogenous ATase activity. The bacterial protein has been shown to act on damage in DNA in the host cells and some of the biological consequences of this are assessed.
EXPERIMENTAL PROCEDURES
Construction of Plasmid. All recombinant DNA manipulations utilized standard technology (31) . The plasmid pO62C has recently been described (28) . It contains the entire coding sequence of the E. coli B 06-AG ATase gene cloned into pUC8 and propagated in the bacterial host DH1 (32 were selected in the same medium containing 500 ,ug of the drug per ml. Cells were cultured continually in G418 unless otherwise stated. Methods of determining cell survival and mutation frequencies at the hypoxanthine guanine phosphoribosyltransferase (HPRT) locus have been described in detail (35) . Transfection of plasmid DNA into mammalian cells was by standard calcium phosphate precipitation (36) .
Preparation of Cellular Protein Extracts. Monolayer cultures of cells were rinsed with phosphate-buffered saline (PBS), harvested by scraping, and resuspended at 107 cells per ml in 50 mM Tris-HCl, pH 8.3/1 mM EDTA/3 mM dithiothreitol/0.5 mM phenylmethylsulfonyl fluoride (Sigma). Cells were disrupted by sonication in ice for three periods of 10 sec each at 12 ,um peak to peak. Cellular debris was removed by centrifugation (10,000 X g for 10 min at 0C), and the supernatants were used for protein estimation (BioRad) and assay of ATase activity.
Assay of ATase Activity. This assay has been described in detail (20) . Briefly, cell extracts were incubated with calf thymus DNA that had been methylated in vitro by reaction with [3H]MNU (30 Ci/mmol; 1 Ci = 37 GBq; Amersham).
DNA was hydrolyzed to acid solubility in 1 M perchloric acid and labeled proteins were recovered by centrifugation and quantitated by liquid scintillation counting. Alternatively, labeled proteins were separated by electrophoresis and visualized by fluorography as described (20) .
Analysis of the Repair of 0-AG. Cells were propagated in DMEM suspension medium/10% fetal calf serum, harvested and resuspended in PBS containing [3H]MNU (1.75 Ci/mmol; Amersham) at 0.17 mM for 1 hr at 37°C; 107 cells were removed for "zero time" measurements and the remaining cells were propagated in suspension from which similar sized aliquots were removed at various times thereafter. DNA was extracted from cells, hydrolyzed in 0.1 M HCl04 at 70°C for 30 min and subjected to Sephadex G-10 chromatography as described (37) . (37) .
RESULTS AND DISCUSSION Construction of Vector for Expression of Bacterial ATase. Fig. 1 shows the strategy of vector construction. The 1100-base-pair insert of pO62C (28) was inserted into the unique BamHI cloning site of pZipneoSV(X)1 in the appropriate transcriptional orientation to yield pJCB06C. When this vector is inserted into the host cellular genome, two mRNA molecules will be transcribed: first, a "full-length" mRNA initiating in the 5' long terminal repeat encompassing the entire sequence and terminating in the 3' long terminal repeat. In this mRNA the first ATG sequence encountered is the first codon of the bacterial ATase gene (24) , hence, bacterial ATase protein will be translated from this molecule. In addition a subgenomic spliced mRNA will occur in which the bacterial ATase sequence has been spliced out to the 3' splice site (SS in Fig. 1 ). The first ATG codon encountered in this molecule is that of the neo gene (38) , and thus cells producing the subgenomic mRNA will exhibit resistance to G418.
Selection of Cells Expressing Bacterial ATase. pJCB06C or control plasmid pZipneoSV(X)1 were transfected into RJKO cells and 12 clones resistant to G418 at 500 ,g/ml were selected, expanded, and assayed for the presence of ATase activity ( Table 1 ). The majority of the G418-resistant (G418R) colonies selected had undetectable levels (<4 fmol per mg of protein) of ATase activity, including the control populations transfected with the parent plasmid. Why 6 of the 10 G418R clones transfected with pJCB06C did not express detectable ATase activity has not yet been investigated.
One possibility is that there may have been rearrangement of plasmid sequence during the transfection and integration processes such that only the neo gene is efficiently transcribed. Nevertheless, one clone, number 8, expresses high levels of ATase activity (1500 fmol per mg ofprotein; i.e., =7 x 104 ATase molecules per cell), and this is higher than the endogenous ATase level found in any mammalian cell we have analyzed to date (unpublished observations). Preliminary Southern blot experiments (data not shown) indicate the presence of multiple copies of pJCB06C integrated into the host genome in a head-to-tail tandem array. In subsequent To demonstrate whether the bacterial protein expressed in these cells was capable of repairing alkylation damage in the host genome, clone 8 and clone 2 cells were exposed to [3H]MNU for 1 hr and DNA was extracted from cells at intervals thereafter. After such treatment, the major alkyla-1 2 tion product is N7-methylguanine (N7-meG), which is lost from DNA by chemical hydrolysis (8, 41) , by glycosylase activity (42) , and by dilution, as a consequence of de novo synthesis of DNA (39) . Fig. 3A shows that these processes were similar in both populations since the initial production of N7-meG and its subsequent loss were the same, and the incorporation of labeled breakdown products of MNU into adenine in DNA were almost identical in the two populations. These results suggest that the presence of the E. coli ATase gene in RJKO cells does not affect endogenous glycosylase activity or DNA synthesis.
In control cells, the initial level of 06-methylguanine (06-meG) was 29 Ixmol per mol of guanine (Fig. 3B ) and the 06-meG/N7-meG ratio was 0.092 ( Fig. 3C) , which is close to the ratio (0.107) found in DNA alkylated in vitro by MNU (3, 41) . Since the initial levels of N7-meG were closely similar in the two populations and since the relative amounts of N7-meG and 06-meG produced in DNA are constant (see ref.
41), the total amount of 06-meG generated in clone 8 cells would also be in this ratio. However, the initial amount of 06-meG in clone 8 cells was considerably lower (6 ,mol per mol of guanine; Fig. 3B ) and the 06-meG/N7-meG ratio was 0.019 ( Fig. 3C ), indicating that these cells were able to repair the majority of the 06-meG produced by this dose of MNU by the end of the 1-hr treatment period. With increasing time after treatment, the amount of 06-meG decreases in both populations because of DNA synthesis, but the loss is more rapid in clone 8 cells. This is reflected first in the 06-meG/N7-meG ratio, which does not change significantly in clone 8 cells (Fig. 3C) Fluorograph of cell extracts after incubation with
[3H]MNU-methylated substrate DNA and NaDodSO4/polyacrylamide gel electrophoresis as described (20) . Lane (Fig. 3D) . It is reasonable to suggest that the more rapid decrease in 06-meG in clone 8 cells is due to the synthesis and/or transport into the nucleus of more bacterial ATase protein. The mechanism of regulation of bacterial ATase gene expression in mammalian cells and whether specific accumulation of the protein in the nucleus takes place are unknown. It is clear from the present results that a pool of bacterial ATase is present in clone 8 cells and that this is capable of rapidly acting on 06-AG, and probably AP, produced in the host genome.
Having generated two clones of RJKO cells that differ, as far as we have ascertained, only in their ability to repair specific oxygen alkylation products in DNA, we could now examine how this repair function would influence the biological effects of alkylating agents under conditions in which the cellular responses to all other alkylation reactions should remain unchanged.
Effect of Bacterial ATase on Cell Survival. The survival of clone 2 and clone 8 cells was determined after exposure to increasing doses of two monofunctional [MNU and methyl methanesulfonate (MeMes)] and two bifunctional [chlorozotocin and nitrogen mustard (HN2)] alkylating agents and the results are shown in Fig. 4 . Clone 8 cells were clearly more resistant to the toxic effects of MNU (Fig. 4A) or chlorozotocin ( Fig. 4C) than were control cells. Little or no difference in survival was observed when the two populations were exposed to MeMes (Fig. 4B) or HN2 (Fig. 4D) . In contrast to MNU, MeMes produces very little 06-AG in DNA [06-meG/N7-meG ratio, 0.004 (3, 41)], and its toxic effects are thought to be due to reaction at nitrogen atoms in DNA, the products of which are substrates for glycosylase enzymes (3, 42, 43) . These results therefore appear to confirm that glycosylase gene expression is the same in both cell lines (see also Fig. 3A) and that ATase-repairable damage does not contribute to the toxic effects of MeMes, whereas it is a major cause of cell death after MNU treatment. Chlorozotocin and HN2 are both DNA crosslinking agents, with the former giving rise to a chloroethylating agent that initially produces a mono-adduct at the 06 position of guanine; this subsequently generates a DNA-DNA interstrand crosslink in a two-stage process (44) . The initial product, 06-chloroethylguanine, has been shown to be a substrate for 06-AG ATase in vitro, which prevents crosslink formation by such agents (45) . The probable lethality of these crosslinks has been implied in experiments with mammalian cells in which ATase activity has been reduced by exposure to N-methyl-N'-nitro-N-nitrosoguanidine (46) (47) (48) or o6-alkylguanines (49) or by infection with virus (11, 12) : such cells are considerably more sensitive to the toxic effects of chloroethylating agents. Since protection against the toxic effects of chlorozotocin was greater than against MNU (Fig.  4 A and C) , which may also kill cells by nitrogen atom alkylation reactions, the present results indicate that ATaserepairable oxygen alkylation products in DNA are probably the most important factors in the toxic effects of chloroethylating agents. However, because pJCB06C contains both ATase functions, it is not yet possible to ascertain the contribution, if any, of AP mono adducts in cell death after exposure to either MNU or chlorozotocin.
HN2 is believed to exert its toxic effects by the formation of interstrand crosslinks through the N7 positions of two guanine residues (50). Our results indirectly support this hypothesis and strongly suggest that ATase-repairable lesions do not form a major contribution to the toxic effects of HN2. This is supported by recent observations (48) that pretreatment of cells with N-methyl-N'-nitro-N-nitrosoguanidine, which depletes 06-AG ATase activity, had no effect on HN2 toxicity.
Effect of ATase Expression on Mutagenicity. The results of treating clone 8 or clone 2 cells with increasing doses of MNU followed by selection of mutants at the HPRT locus are shown in Fig. 5 . Because a different dose range of MNU had to be used for the two populations (Fig. 4A) , the results are plotted as frequency of 6-thioguanine resistant (HPRT-) colonies per cell versus surviving fraction at that dose of MNU. It is clear that clone 8 cells are nonmutable at this was evident at any dose tested. Clone 2 cells, on the other hand, were mutable at the HPRT locus by MNU at frequencies in the range expected for Chinese hamster V79 fibroblasts (35) . It is believed that monofunctional alkylating agents exert their mutagenic effects through 0 atom alkylation and 06-AG in particular (4, (14) (15) (16) , and our results suggest that the principal mutagenic lesions produced in DNA in mammalian cells by MNU are substrates for the E. coli dual ATase protein. The relative contributions of 06-AG, AP, and other minor 0 atom alkylated bases will be assessed in further experiments.
The present results indicate that permanent expression of a bacterial DNA repair gene can be achieved in mammalian cells by means of a retrovirus-based drug-selectable plasmid and that the protein transcribed is capable of penetrating the host cell nucleus and acting on DNA damaged by alkylating agents. As a consequence, the cells are less susceptible to the toxic and mutagenic effects of those agents that react extensively with oxygen sites in the DNA. The bacterial ATase protein has been shown to have two active sites that transfer alkyl groups from AP and 06-AG, with the latter also acting on the minor product 04-alkylthymine (51) . Experiments in which vectors are constructed that will provide these two repair functions individually may allow us to elucidate the relative importance of these types of damage in the biological effects of alkylating agents. We would also like to produce transgenic animals that might express high levels of the bacterial protein in their tissues in order to assess whether the repair of specific types of alkylation damage in vivo can protect against carcinogenesis.
